Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035363 | SCV000059011 | likely benign | not specified | 2012-11-15 | criteria provided, single submitter | clinical testing | Ile336Ile in exon 12 of MYBPC3: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. Ile336Ile in exon 12 of MYBPC3 (allele fre quency = n/a) |
Ambry Genetics | RCV000241564 | SCV000317964 | likely benign | Cardiovascular phenotype | 2021-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001711147 | SCV000513752 | likely benign | not provided | 2018-07-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28679633) |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000607104 | SCV000744856 | likely benign | Hypertrophic cardiomyopathy 4 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000629171 | SCV000750087 | likely benign | Hypertrophic cardiomyopathy | 2023-01-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769353 | SCV000900741 | likely benign | Cardiomyopathy | 2016-03-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769353 | SCV004358753 | uncertain significance | Cardiomyopathy | 2023-07-27 | criteria provided, single submitter | clinical testing | This synonymous variant causes a nucleotide substitution but does not change the encoded amino acid at codon 336 of the MYBPC3 protein. Splice prediction tools are inconclusive regarding the impact of this variant on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in homozygous state in an individual affected with hypertrophic cardiomyopathy, cryptorchidism, and hypotonia (doi:10.34087/cbusbed.1052808). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV000629171 | SCV004834690 | uncertain significance | Hypertrophic cardiomyopathy | 2023-08-15 | criteria provided, single submitter | clinical testing | This synonymous variant causes a nucleotide substitution but does not change the encoded amino acid at codon 336 of the MYBPC3 protein. Splice prediction tools are inconclusive regarding the impact of this variant on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in homozygous state in an individual affected with hypertrophic cardiomyopathy, cryptorchidism, and hypotonia (doi:10.34087/cbusbed.1052808). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Diagnostic Laboratory, |
RCV000607104 | SCV000733055 | likely benign | Hypertrophic cardiomyopathy 4 | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001711147 | SCV001957742 | likely benign | not provided | no assertion criteria provided | clinical testing |